CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Phase Contrast Mammographyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00467727
NCT00467727N/ACompleted
CompareCT.gov

Lesion Characteristics' Visibility With Phase Contrast Mammography in Comparison to X-Ray Mammography for Women Undergoing X-Ray Diagnostic Mammography

UNC Lineberger Comprehensive Cancer Center·interventional·Posted May 1, 2007·Updated May 1, 2012

In Brief

A clinical study evaluating Phase Contrast Mammography for Breast Cancer. Completed, enrolled 53 participants across 1 site.

Detailed Summary

To determine if diagnostic phase contrast mammography (PCM) will provide improved image detail in assessing lesion characteristics when compared to diagnostic x-ray mammography (XM).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 1, 2007
Enrollment StartApr 1, 2007
Primary CompletionMar 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 19.2 years ago

Interventions

Phase Contrast Mammographyother

Standard and magnification views